{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:26:55Z","timestamp":1777865215586,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["201803040002"],"award-info":[{"award-number":["201803040002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["31500740"],"award-info":[{"award-number":["31500740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["81561128007"],"award-info":[{"award-number":["81561128007"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030310442"],"award-info":[{"award-number":["2015A030310442"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730060"],"award-info":[{"award-number":["81730060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21877132"],"award-info":[{"award-number":["21877132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21572281"],"award-info":[{"award-number":["21572281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009334","name":"Pearl River S and T Nova Program of Guangzhou","doi-asserted-by":"publisher","award":["201806010118"],"award-info":[{"award-number":["201806010118"]}],"id":[{"id":"10.13039\/501100009334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["201704020226"],"award-info":[{"award-number":["201704020226"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012540","name":"Guangdong Province Introduction of Innovative R&D Team","doi-asserted-by":"publisher","award":["2009010058"],"award-info":[{"award-number":["2009010058"]}],"id":[{"id":"10.13039\/100012540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejmech.2019.01.059","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:47:44Z","timestamp":1549327664000},"page":"480-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors"],"prefix":"10.1016","volume":"166","author":[{"given":"Ting","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.01.059_bib1","series-title":"Global Hepatitis Report, 2017","author":"Organization","year":"2017"},{"key":"10.1016\/j.ejmech.2019.01.059_bib2","first-page":"285","article-title":"Update on hepatitis B virus infection: focus on treatment","volume":"2","author":"Hadziyannis","year":"2014","journal-title":"J.\u00a0Clin. Trans. Hepatol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib3","doi-asserted-by":"crossref","first-page":"13293","DOI":"10.3748\/wjg.v20.i37.13293","article-title":"Update on hepatitis B virus infection","volume":"20","author":"You","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.apsb.2014.05.002","article-title":"Therapeutic strategies for a functional cure of chronic hepatitis B virus infection","volume":"4","author":"Chang","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2019.01.059_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jvh.12307","article-title":"Treatment options beyond IFNalpha and NUCs for chronic HBV infection: expectations for tomorrow","volume":"21","author":"Baltayiannis","year":"2014","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.ejmech.2019.01.059_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-015-2341-x","article-title":"Prevention of hepatitis B virus infection: from the past to the future","volume":"34","author":"Orlando","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.059_bib7","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/acs.jmedchem.6b00879","article-title":"Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B virus (HBV) capsid inhibitors","volume":"59","author":"Qiu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.059_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tim.2010.11.003","article-title":"Virus assembly, allostery and antivirals","volume":"19","author":"Zlotnick","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib9","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1021\/acs.jmedchem.7b00083","article-title":"Discovery and pre-clinical characterization of third-generation 4-H heteroaryldihydropyrimidine (HAP) analogues as hepatitis B virus (HBV) capsid inhibitors","volume":"60","author":"Qiu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.059_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.01.059_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.01.059_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: a pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2019.01.059_bib13","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/JVI.03545-14","article-title":"The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription","volume":"89","author":"Tan","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib14","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1038\/nmicrobiol.2017.98","article-title":"HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly","volume":"2","author":"Patel","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib15","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/JVI.76.10.4848-4854.2002","article-title":"A\u00a0small molecule inhibits and misdirects assembly of hepatitis B virus capsids","volume":"76","author":"Zlotnick","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib16","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A\u00a0novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.01.059_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2015.11.004","article-title":"Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation","volume":"125","author":"Yang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2019.01.059_bib18","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1128\/JVI.00582-13","article-title":"Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids","volume":"87","author":"Campagna","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/acsinfecdis.6b00159","article-title":"Optimization and synthesis of pyridazinone derivatives as novel inhibitors of hepatitis B virus by inducing genome-free capsid formation","volume":"3","author":"Lu","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.059_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coph.2016.08.004","article-title":"Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection","volume":"30","author":"Cole","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib21","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/AAC.46.9.3057-3060.2002","article-title":"Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in\u00a0vitro","volume":"46","author":"Delaney","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.01.059_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3851\/IMP2152","article-title":"In\u00a0vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations","volume":"17","author":"Wang","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2019.01.059_bib23","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.01091-13","article-title":"Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.01.059_bib24","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2019.01.059_bib25","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.03058-15","article-title":"Hepatitis B virus capsids have diverse structural responses to small-molecule ligands bound to the heteroaryldihydropyrimidine pocket","volume":"90","author":"Venkatakrishnan","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib26","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A\u00a0heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Stray","year":"2005","journal-title":"P\u00a0Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2019.01.059_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nbt1187","article-title":"An in\u00a0vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly","volume":"24","author":"Stray","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.01.059_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nprot.2007.60","article-title":"In\u00a0vitro screening for molecules that affect virus capsid assembly (and other protein association reactions)","volume":"2","author":"Zlotnick","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2019.01.059_bib29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bmc.2014.12.006","article-title":"Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformans","volume":"23","author":"Khalil","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.059_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bmcl.2009.11.093","article-title":"Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes","volume":"20","author":"Kitas","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.059_bib31","series-title":"Preparation of Sulfonamides, Particularly N-(thiazol-2-yl)sulfonamides, as Inhibitors of Hydroxysteroid Dehydrogenases, Especially 11\u03b2-Hydroxysteroid Dehydrogenase, WO 2006066109, A2","author":"Brennan","year":"2006"},{"key":"10.1016\/j.ejmech.2019.01.059_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmr.801","article-title":"BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly","volume":"19","author":"Stray","year":"2006","journal-title":"J.\u00a0Mol. Recogn."},{"key":"10.1016\/j.ejmech.2019.01.059_bib33","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J.\u00a0Virol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:57:15Z","timestamp":1777528635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419300583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"alternative-id":["S0223523419300583"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.059","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}